Normalization of acquired QT prolongation in humans by intravenous potassium

Circulation

Volumn 96, Issue 7, 1997, Pages 2149-2154

  Choy, Anna Maria ^a   Lang, Chim C ^a   Chomsky, Don M ^a   Rayos, Glenn H ^a   Wilson, John R ^a   Roden, Dan M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Heart failure; Potassium; Quinidine

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; POTASSIUM CHLORIDE; QUINIDINE SULFATE;

ADULT; ARRHYTHMOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; MALE; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; T WAVE;

EID: 0030848673     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2149     Document Type: Article

References (48)

1. + sensitivity. Pflugers Arch. 1989;414:S88-S92.
2. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E. Sudden cardiac death in heart failure: the role of abnormal repolarization. Circulation. 1994;90:2534-2539.
3. Nabauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:386-394.
4. McAllister RE, Noble D. The time and voltage dependence of the slow outward current in cardiac Purkinje fibres. J Physiol. 1966;186:632-662.
5. Dudel J, Peper K, Rudel R, Trautwein W. The potassium component of membrane current in Purkinje fibers. Pflugers Arch. 1967;296:308-327.
6. + currents. Pflugers Arch. 1992;420:180-186.
7. Kr potassium channel. Cell. 1995;81:299-307.
8. Compton SJ, Lux RL, Ramsay MR, Strelich KR, Sanguinetti MC, Green LS, Keating MT, Mason JW. Genetically-defined therapy of inherited long-QT syndrome: correction of abnormal repolarization by potassium. Circulation. 1996;94:1018-1022.
9. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
10. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J. 1990;63:342-344.
11. Barr CJ, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343:327-329.
12. Perkiomaki JS, Ikaheimo MJ, Pikkujamsa SM, Rantala A, Lilja M, Keisaniemi YA, Huikuri HV. Dispersion of the QT interval and autonomie modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension. 1996;28:16-21.
13. Siscovick DS, Raghunathan TE, Rautaharju P, Psaty BM, Cobb LA, Wagner EH. Clinically silent electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients. Circulation. 1996;94:1329-1333.
14. Martin AB, Garson A Jr, Perry JC. Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children. Am Heart J. 1994;127:64-70.
15. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993;72:973-976.
16. Schwartz PJ, Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation. 1978;56:1074-1077.
17. Ahnve S, Helmers C, Lundman T, Rehnquist N, Sjorgren A. QTc intervals in acute myocardial infarction: first year prognostic implications. Clin Cardiol. 1980;3:303-308.
18. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes: disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation. 1992;86:1376-1382.
19. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval: a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 1994;89:1681-1689.
20. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-385.
21. + current in guinea pig ventricular cells. J Pharmacol Exp Ther. 1992;262:99-108.
22. Kr) in AT-1 cells: concentration-, time-, voltage-, and use-dependent effects. Circulation. 1995;91:1799-1806.
23. Gwilt M, Arrowsmith JE, Blackburn KJ, Burges RA, Cross PE, Dalrymple HW, Higgins AJ. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J Pharmacol Exp Ther. 1991;256:318-324.
24. + current by dofetilide. Circ Res. 1993;72:75-83.
25. Kr: implications for torsades de pointes and reverse use-dependence. Circulation. 1996;93:407-411.
26. Imaizumi Y, Giles WR. Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Phvsiol. 1987; 253:H704-H708.
27. Balser JR, Bennett PB, Hondeghem LM, Roden DM. Suppression of time-dependent outward current in guinea pig ventricular myocytes: actions of quinidine and amiodarone. Circ Res. 1991;69:519-529.
28. Snyders DJ, Knoth KM, Roherds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol. 1992;41:322-330.
29. Balser JR, Roden DM, Bennett PB. Single inward rectifier potassium channels in guinea pig ventricular myocytes: effects of quinidine. Biophys J. 1991;59:150-161.
30. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther. 1985;232:817-825.
31. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
32. Mörike K, Fish F, Mosqueda-Garcia R, Smith M, Wood A, Roden D. Sympathetic activity: a modulator of quinidine disposition? Clin Pharmacol Ther. 1993;53:169. Abstract.
33. Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353-370.
34. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res. 1996;79:669-675.
35. max and the transient outward current. Circulation. 1992;85:1175-1188.
36. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 1994;28:933-946.
37. Benitah JP, Gomez AM, Bailly P, Da Ponte JP, Berson G, Delgado C, Lorente P. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol. 1993;469:111-138.
38. Kääb S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262-273.
39. + channel in ventricular muscle: a molecular correlate for the transient outward current. Circ Res. 1996;79:659-668.
40. Choy AMJ, Kupershmidt S, Lang CC, Pierson RN Jr, Roden DM. Regional expression of HERG and KvLQT1 in heart failure. Circulation. 1996;94(suppl I):I-164. Abstract.
41. + channel currents in rat ventricular myocytes. J Gen Physiol. 1996;108:405-419.
42. Mariano DJ, Schomer SJ, Rea RF. Effects of quinidine on vascular resistance and sympathetic nerve activity in humans. J Am Coll Cardiol. 1992;20:1411-1416.
43. Vandenberg CA. Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc Natl Acad Sci U S A. 1987;84:2560-2564.
44. 2+. Nature. 1987;325:156-158.
45. Higham PD, Hilton CJ, Aitcheson DA, Furniss SS, Bourke JP, Campbell RWF. QT dispersion does reflect regional variation in ventricular recovery. Circulation. 1992;8(suppl I):I-392. Abstract.
46. Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 1958;6:378-388.
47. Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI. Torsades de pointes with almokalant, a new class III antiarrhythmic drug. Am Heart J. 1993;126:1008-1011.
48. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84: 1516-1523.